CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)
NCT ID: NCT01354184
Last Updated: 2012-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRD007 10 mg tablet
CRD007
CRD007 25 mg tablet
CRD007
CRD007 40 mg tablet
CRD007
CRD007 matching placebo tablet
CRD007 matching placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CRD007
CRD007 matching placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known diabetes
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RSPR Pharma AB
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henrik Sillesen, MD DMSc
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, University of Copenhagen, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aalborg Hospital, Department of Vascular Surgery V
Aalborg, , Denmark
Aarhus Universitetshospital Skejby, Hjerte-Lunge-Kar kir. afd. T
Aarhus, , Denmark
Rigshospitalet, Karkirurgisk afdeling RK 3111
Copenhagen, , Denmark
Sygehus Lillebælt, Karkirurgisk Forskningsenhed
Kolding, , Denmark
Regionshospitalet Viborg, Karkiurgisk Forskningssektion
Viborg, , Denmark
Borås Hospital, Department of Surgery
Borås, , Sweden
Mälarsjukhuset, Team Kärl Kir. Klin.
Eskilstuna, , Sweden
Sahlgrenska Universitetssjukhuset
Gothenburg, , Sweden
Skånes Universitets Sjukhus, Institution of Surgical Science
Malmo, , Sweden
Universitetssjukhuset Örebro, Kirurgkliniken, Kärlsektionen
Örebro, , Sweden
Karolinska University Hospital, Kärlkirurgiska Kliniken
Stockholm, , Sweden
Uppsala University Hospital
Uppsala, , Sweden
Centrallaserettet, Kärlkirurgiska Kliniken
Västerås, , Sweden
St George's Hospital NHS Trust
London, , United Kingdom
University Hospital of South Manchester
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sillesen H, Eldrup N, Hultgren R, Lindeman J, Bredahl K, Thompson M, Wanhainen A, Wingren U, Swedenborg J; AORTA Trial Investigators. Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm. Br J Surg. 2015 Jul;102(8):894-901. doi: 10.1002/bjs.9824. Epub 2015 May 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cardoz-003
Identifier Type: -
Identifier Source: org_study_id